AbbVie Inc - Cash Flows Other Operating

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Cash-Flows-Other-Operating" stands at -0.874 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2020.

AbbVie Inc's third quarter result of 0.193 Billion USD for the item "Cash Flows Other Operating" represents an increase of 170.96 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of 0.193 Billion USD for the item "Cash Flows Other Operating" represents an increase of 169.68 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of -0.874 Billion USD for the item "Cash Flows Other Operating" represents an increase of 34.97 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.20 Billion United States Dollars compared to the value the year prior.
The 1 year change is 1.20 Billion United States Dollars.
The 3 year change is 1.29 Billion United States Dollars.
The 5 year change is -0.046 Billion United States Dollars.

The Serie's long term average value is -0.168 Billion United States Dollars. It's latest available value, on 09/30/2025, is -0.706 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +2.14 Billion.
The Serie's change in United States Dollars from it's maximum value, on 09/30/2019, to it's latest available value, on 09/30/2025, is -7.40 Billion.